Page last updated: 2024-08-22

tiletamine hydrochloride and Carcinoma, Non-Small Cell Lung

tiletamine hydrochloride has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baird, AM; Barr, MP; Cuffe, S; Finn, SP; Gately, K; Godwin, P; Heavey, S; O'Byrne, KJ; Umezawa, K	1

Other Studies

1 other study(ies) available for tiletamine hydrochloride and Carcinoma, Non-Small Cell Lung

Article	Year
Strategic targeting of the PI3K-NFκB axis in cisplatin-resistant NSCLC. Cancer biology & therapy, 2014, Volume: 15, Issue:10 Topics: Antineoplastic Agents; Benzamides; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cisplatin; Cyclohexanones; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Pyrimidines; Transcriptome	2014

Article

Year

Strategic targeting of the PI3K-NFκB axis in cisplatin-resistant NSCLC.

Cancer biology & therapy, 2014, Volume: 15, Issue:10

Topics: Antineoplastic Agents; Benzamides; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cisplatin; Cyclohexanones; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Pyrimidines; Transcriptome

2014